Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6.99M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.94M
-
Shares change
-
-7.35K
-
Total reported value, excl. options
-
$3.34M
-
Value change
-
-$12.4K
-
Number of buys
-
7
-
Number of sells
-
-8
-
Price
-
$1.72
Significant Holders of Minerva Neurosciences, Inc. - Common Stock (NERV) as of Q2 2025
22 filings reported holding NERV - Minerva Neurosciences, Inc. - Common Stock as of Q2 2025.
Minerva Neurosciences, Inc. - Common Stock (NERV) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.94M shares
of 6.99M outstanding shares and own 27.8% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1.35M shares), VANGUARD GROUP INC (252K shares), RENAISSANCE TECHNOLOGIES LLC (111K shares), GEODE CAPITAL MANAGEMENT, LLC (75.6K shares), BlackRock, Inc. (72.7K shares), Apella Capital, LLC (20.9K shares), ACADIAN ASSET MANAGEMENT LLC (17.4K shares), STATE STREET CORP (16.5K shares), ADAR1 Capital Management, LLC (12.4K shares), and MORGAN STANLEY (11K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.